Lupin has received euro 20 million from Laboratories Servier of France for the sale of certain patent applications and other related intellectual property rights for Perindopril for multiple countries."The income from this sale significantly boosts our performance for the previous quarter. It obviously goes a long way to demonstrate our Research and IP capabilities," Dr. Kamal Sharma, managing director, Lupin, said.
